Data sources:
Data collection started on 10 February 2020 and finished on 14 August
2020. We have chosen random patients from ENT rhinology and immunology
clinics. During Pre-COVID phase of this survey, patients who came to
attend clinic were verbally asked if they are using steroid nose spray
and if they want to be a part of the survey. If the answer to both the
questions was “yes” then the survey responses were recorded from those
patients. Similarly, during COVID-19 outbreak, patients booked into the
clinic who were using steroid nose spray were contacted by phone and if
they agreed to be a part of this survey then their responses were
recorded.
Study size : Data was collected from 100 patients.